• Cordyceps Sunshine Biotech launched an offshore Regulation S private placement of unregistered ordinary shares at US$ 2.52 each.
• Deal targets about US$ 10 million from 3,968,254 shares.
• Maximum size set at 5,952,381 shares for about US$ 15 million.
• Company can run rolling closings, accept partial orders, or reject subscriptions.
• Proceeds earmarked for platform development, regulatory work, commercialization, public-company compliance, working capital, professional fees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cordyceps Sunshine Biotech Holdings Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-096447), on September 02, 2026, and is solely responsible for the information contained therein.